MetaVia (MTVA) Competitors $0.69 +0.02 (+2.60%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock MTVA vs. SLGL, HOWL, DRRX, PDSB, DTIL, IZTC, KLRS, IMMX, ICCC, and ATNMShould you be buying MetaVia stock or one of its competitors? The main competitors of MetaVia include Sol-Gel Technologies (SLGL), Werewolf Therapeutics (HOWL), DURECT (DRRX), PDS Biotechnology (PDSB), Precision BioSciences (DTIL), Invizyne Technologies (IZTC), Kalaris Therapeutics (KLRS), Immix Biopharma (IMMX), ImmuCell (ICCC), and Actinium Pharmaceuticals (ATNM). These companies are all part of the "pharmaceutical products" industry. MetaVia vs. Its Competitors Sol-Gel Technologies Werewolf Therapeutics DURECT PDS Biotechnology Precision BioSciences Invizyne Technologies Kalaris Therapeutics Immix Biopharma ImmuCell Actinium Pharmaceuticals MetaVia (NASDAQ:MTVA) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment. Do analysts prefer MTVA or SLGL? MetaVia currently has a consensus target price of $7.50, indicating a potential upside of 991.86%. Given MetaVia's stronger consensus rating and higher possible upside, analysts plainly believe MetaVia is more favorable than Sol-Gel Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MetaVia 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer MTVA or SLGL? In the previous week, Sol-Gel Technologies had 2 more articles in the media than MetaVia. MarketBeat recorded 4 mentions for Sol-Gel Technologies and 2 mentions for MetaVia. Sol-Gel Technologies' average media sentiment score of 1.00 beat MetaVia's score of 0.00 indicating that Sol-Gel Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MetaVia 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sol-Gel Technologies 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in MTVA or SLGL? 1.4% of MetaVia shares are owned by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are owned by institutional investors. 0.8% of MetaVia shares are owned by company insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, MTVA or SLGL? MetaVia has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Which has higher valuation and earnings, MTVA or SLGL? Sol-Gel Technologies has higher revenue and earnings than MetaVia. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMetaViaN/AN/A-$27.59MN/AN/ASol-Gel Technologies$11.54M6.77-$10.58M-$1.23-22.76 Is MTVA or SLGL more profitable? MetaVia has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -14.25%. Sol-Gel Technologies' return on equity of -11.80% beat MetaVia's return on equity.Company Net Margins Return on Equity Return on Assets MetaViaN/A -212.00% -107.21% Sol-Gel Technologies -14.25%-11.80%-9.39% SummarySol-Gel Technologies beats MetaVia on 9 of the 13 factors compared between the two stocks. Get MetaVia News Delivered to You Automatically Sign up to receive the latest news and ratings for MTVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MTVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MTVA vs. The Competition Export to ExcelMetricMetaViaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.20M$3.13B$5.75B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E RatioN/A20.8978.4326.42Price / SalesN/A458.96546.94119.09Price / CashN/A44.5237.0558.92Price / Book0.759.9310.916.06Net Income-$27.59M-$53.38M$3.29B$266.28M7 Day Performance6.17%0.05%0.01%-0.76%1 Month Performance15.17%7.08%7.06%3.83%1 Year PerformanceN/A11.92%50.09%24.39% MetaVia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MTVAMetaVia1.8854 of 5 stars$0.69+2.6%$7.50+991.9%N/A$16.20MN/A0.008Analyst ForecastSLGLSol-Gel Technologies1.6899 of 5 stars$21.95-6.6%N/A+248.6%$61.24M$11.54M-17.8550News CoveragePositive NewsShort Interest ↓Gap UpHOWLWerewolf Therapeutics2.8794 of 5 stars$1.33-2.2%$8.00+501.5%-33.2%$60.82M$1.88M-0.8140DRRXDURECT0.9704 of 5 stars$1.93flatN/A+32.9%$59.93M$1.66M-19.3080PDSBPDS Biotechnology2.6399 of 5 stars$1.28-0.8%$10.00+681.3%-57.0%$59.69MN/A-1.3920Gap UpDTILPrecision BioSciences3.9428 of 5 stars$5.01-0.6%$47.00+838.1%-51.4%$59.07M$68.70M-0.57200IZTCInvizyne TechnologiesN/A$9.31flatN/AN/A$58.21MN/A0.0029News CoverageKLRSKalaris Therapeutics1.254 of 5 stars$3.08+20.3%$3.00-2.6%N/A$57.60MN/A0.00110Analyst ForecastGap DownHigh Trading VolumeIMMXImmix Biopharma3.18 of 5 stars$1.96-7.5%$7.00+257.1%+8.8%$56.51MN/A-2.559Short Interest ↓High Trading VolumeICCCImmuCell0.6366 of 5 stars$6.10-2.4%N/A+68.9%$55.21M$26.49M32.1170Positive NewsATNMActinium Pharmaceuticals1.7491 of 5 stars$1.76-1.1%$4.50+155.7%-8.6%$54.91MN/A-1.2730Short Interest ↑ Related Companies and Tools Related Companies SLGL Alternatives HOWL Alternatives DRRX Alternatives PDSB Alternatives DTIL Alternatives IZTC Alternatives KLRS Alternatives IMMX Alternatives ICCC Alternatives ATNM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MTVA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MetaVia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MetaVia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MTVA Stock Alerts